posted on 2022-07-15, 15:38authored byJingyu Sun, Jinping Wang, Wei Hu, Yuhao Wang, Qiang Zhang, Xiaotong Hu, Tsengming Chou, Beilu Zhang, Cosmo Gallaro, Meghan Halloran, Lyu Liang, Lei Ren, Hongjun Wang
The characteristic hypoxia of solid tumors and inadequate
oxygen
supply become a key causation of the resistance to chemotherapy in
cancer treatment. Herein, a bimetallic oxygen nanogenerator, i.e., porous Au@Pt core–shell nanostructures,
is particularly developed to reduce the multidrug resistance by oxygenating
the tumor along with synergistic chemo-photothermal therapy for efficient
tumor eradication. The porous platinum (Pt) shell was able to catalyze
oxygen generation from endogenous hydrogen peroxide in the tumor,
reducing the exocytosis of doxorubicin (DOX) via suppressed
expression of hypoxia-inducible factor-1α, multidrug resistance
gene 1, and P-glycoprotein. The strong absorbance of Au@Pt nanostructures
in NIR window II enabled NIR-II photothermal therapy. Further incorporation
of DOX into the mesopores of Au@Pt nanostructures with the assistance
of phase change materials (PCM) led to the formulation of Au@Pt-DOX-PCM-PEG
nanotherapeutics for NIR-II-activated chemotherapy. This work presents
an efficient H2O2-driven oxygenerator for enhanced
hypoxia-dampened chemotherapy and NIR-II photothermal therapy.